Gilead Sciences Inc. (NASDAQ:GILD) traded down 1.8% during trading on Monday . The stock traded as low as $77.63 and last traded at $78.33, with a volume of 10,657,487 shares traded. The stock had previously closed …
Drug stock Gilead Sciences, Inc. (NASDAQ:GILD) is down today, last seen 0.9% lower at $70.01, and earlier hit a new two-year low of $69.78. The stock has spent the better part of the last year succumbing to pressure …
Players
The Company gained 1.26% and finished at $86.55. The daily volume was measured at 7.62 million shares. The 52-week high of the share price is $120.37 and the 52-week low is $77.92. The company has a market cap of …
With a market cap of 94569.48, Gilead Sciences Inc. (NASDAQ:GILD) has a large market cap size. Gilead Sciences Inc. (NASDAQ: GILD) has been on the stock market since its IPO date on the 1/22/1992. Gilead
NASDAQ
Investor interest comes from unconfirmed rumors about Carl Icahn saying …
Gilead Sciences
Few sectors have struggled as much as the biotech sector over the last nine months. After seeing the sector come under scrutiny for pricing practices last summer, along with the pharmaceutical sector, the biotech …
Gilead Sciences, Inc. (NASDAQ:GILD) has fetched top momentum style rating. It serves as a major indicator to confirm as to stock holds a positive place and offers trading opportunity to traders as well as investors. …
Sell-side Street analysts covering Gilead Sciences, Inc. (NASDAQ:GILD) presently have an average rating of 1.81 on company shares. This consensus rating is using 14 analysts polled by Zacks Research. On a …
NASDAQ
Gilead Sciences, Inc. (NASDAQ:GILD) was downgraded by analysts at TheStreet from a “b-” rating to a “hold” rating in a report issued on Wednesday. Several other analysts also recently issued reports on the stock. …